ISRCTN47637497已完成不适用
Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery
Erasmus Medical Centre (Netherlands)0 个研究点目标入组 6,000 人开始时间: 2007年3月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 6,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Aged 40 years or older
- •2. Scheduled for elective non-cardiac surgery
- •3. Have an estimated risk for cardiovascular death of more than 1%
排除标准
- •1. The use of beta-blockers
- •2. A contraindication for beta-blocker use
- •3. The use of statins prior to randomisation
- •4. A contraindication for statin use
- •5. Unstable coronary heart disease, evidence of three-vessel disease or left main disease
- •6. Elevated cholesterol according to the national cholesterol consensus
- •7. Emergency surgery
- •8. Inability or unwillingness to provide written informed consent
- •9. Previous participation in this same trial
研究者
相似试验
招募中
不适用
Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery.non-cardiac surgerybeta-blockerstatinperioperative cardiac complicationsNL-OMON21523Department of Anesthesiology, Erasmus MC Rotterdam, the Netherlands6,000
进行中（未招募）
1 期
Effect of pravastatin or fluvastatin and add-on valsartan on inflammatory markers and peripheral endothelial function in patients with acute coronary syndromepatients with NSTEMIAcute coronary syndromeEUCTR2004-003235-31-ATDiv. of Cardiology, Innsbruck Medical University80
尚未招募
4 期
The effect of combination of rosuvastatin and fenofibrate and metoprolol on the coronary atheroma plaque progression detected by multi-detector spiral computed tomographycoronary artery diseaseCardiovascular - Coronary heart diseaseMetabolic and Endocrine - Other metabolic disordershyperlipidemiaACTRN12611000394943Peking University Health Science Center520
进行中（未招募）
1 期
Treatment effects of Bisoprolol and Verapamil in symptomatic patients with non-obstructive hypertrophic cardiomyopathyon-obstructive hypertrophic cardiomyopathyCTIS2024-515346-17-00Aarhus Universitetshospital140
进行中（未招募）
1 期
The effect of Bisoprolol and Verapamil in non-obstructive hypertrophic cardiomyopathyon-obstructive Hypertrophic cardiomyopathyMedDRA version: 20.0Level: PTClassification code 10007636Term: CardiomyopathySystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10049813Term: Non-obstructive cardiomyopathySystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 27.0Level: PTClassification code 10020871Term: Hypertrophic cardiomyopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.0Level: LLTClassification code 10061029Term: Cardiomyopathy primarySystem Organ Class: 10007541 - Cardiac disordersEUCTR2021-006953-77-DKAarhus University Hospital140